[Asia Economy Reporter Jeon Jin-young] Iwon Compotech announced on the 14th that it will acquire 25,000 shares of Innovation, a new drug development and research company, for 2.5 billion KRW. After acquiring the shares, Iwon Compotech's stake in Innovation will be 29.41%. Iwon Compotech stated that the purpose of this share acquisition is "to secure growth engines and generate profits through business diversification."



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing